Matrix Metalloproteinase-13 Predominates over Matrix Metalloproteinase-8 As the Functional Interstitial Collagenase in Mouse Atheromata

Overview

Journal Arterioscler Thromb Vasc Biol

Date 2014 Apr 12

PMID 24723558

Citations 27

Authors

Thibaut Quillard

Haniel Alves Araujo

Gregory Franck

Yevgenia Tesmenitsky

Peter Libby

Affiliations

Soon will be listed here.

Abstract

Objective: Substantial evidence implicates interstitial collagenases of the matrix metalloproteinase (MMP) family in plaque rupture and fatal thrombosis. Understanding the compensatory mechanisms that may influence the expression of these enzymes and their functions, therefore, has important clinical implications. This study assessed in mice the relative effect of the 2 principal mouse collagenases on collagen content and other plaque characteristics.

Approach And Results: Apolipoprotein E-deficient (apoE(-/-)) mice, MMP-13(-/-) apoE(-/-), MMP-8(-/-) apoE(-/-) double knockout mice, and MMP-13(-/-) MMP-8(-/-) apoE(-/-) triple knockout mice consumed a high-cholesterol diet for 10 and 24 weeks. Both double knockout and triple knockout mice showed comparable atherosclerotic lesion formation compared with apoE(-/-) controls. Analysis of aortic root sections indicated that lesions of MMP-8/MMP-13-deficient and MMP-13-deficient mice accumulate more fibrillar collagen than apoE(-/-) controls and MMP-8(-/-) apoE(-/-) double knockout. We further tested the relative effect of MMPs on plaque collagenolysis using in situ zymography. MMP-13 deletion alone abrogated collagenolytic activity in lesions, indicating a predominant role for MMP-13 in this process. MMP-13 and MMP-13/MMP-8 deficiency did not alter macrophage content but associated with reduced accumulation of smooth muscle cells.

Conclusions: These results show that among MMP interstitial collagenases in mice, MMP-13 prevails over MMP-8 in collagen degradation in atheromata. These findings provide a rationale for the identification and selective targeting a predominant collagenase for modulating key aspects of plaque structure considered critical in clinical complications, although they do not translate directly to human lesions, which also contain MMP-1.

Citing Articles

Reversal of atherosclerosis by restoration of vascular copper homeostasis.

Zuo X, Ding X, Zhang Y, Kang Y Exp Biol Med (Maywood). 2024; 249:10185.

PMID: 38978540 PMC: 11228934. DOI: 10.3389/ebm.2024.10185.

Matrix metallopeptidase 9 contributes to the beginning of plaque and is a potential biomarker for the early identification of atherosclerosis in asymptomatic patients with diabetes.

Liu B, Su L, Loo S, Gao Y, Khin E, Kong X Front Endocrinol (Lausanne). 2024; 15:1369369.

PMID: 38660518 PMC: 11039961. DOI: 10.3389/fendo.2024.1369369.

Inhibiting MMP13 Attenuates Deep Vein Thrombosis in a Mouse Model by Reducing the Expression of Pdpn.

Luo J, Zhou J, Luo J, Wang H, Zhao X, Zhou R Curr Med Sci. 2024; 44(2):369-379.

PMID: 38619683 DOI: 10.1007/s11596-024-2862-6.

The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis.

Mukherjee A, Das B Biomater Biosyst. 2024; 13:100090.

PMID: 38440290 PMC: 10910010. DOI: 10.1016/j.bbiosy.2024.100090.

Current advances in the imaging of atherosclerotic vulnerable plaque using nanoparticles.

Zhang M, Xie Z, Long H, Ren K, Hou L, Wang Y Mater Today Bio. 2022; 14:100236.

PMID: 35341094 PMC: 8943324. DOI: 10.1016/j.mtbio.2022.100236.

References

Krzeski P, Buckland-Wright C, Balint G, Cline G, Stoner K, Lyon R . Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. Arthritis Res Ther. 2007; 9(5):R109. PMC: 2212568. DOI: 10.1186/ar2315. View

Galis Z, Sukhova G, Lark M, Libby P . Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994; 94(6):2493-503. PMC: 330083. DOI: 10.1172/JCI117619. View

Aikawa M, Rabkin E, Okada Y, Voglic S, Clinton S, Brinckerhoff C . Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation. 1998; 97(24):2433-44. DOI: 10.1161/01.cir.97.24.2433. View

Lindsey M, Yoshioka J, Macgillivray C, Muangman S, Gannon J, Verghese A . Effect of a cleavage-resistant collagen mutation on left ventricular remodeling. Circ Res. 2003; 93(3):238-45. DOI: 10.1161/01.RES.0000085580.45279.60. View

Libby P . Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med. 2013; 368(21):2004-13. DOI: 10.1056/NEJMra1216063. View

Drummond A, Beckett P, Brown P, Bone E, Davidson A, Galloway W . Preclinical and clinical studies of MMP inhibitors in cancer. Ann N Y Acad Sci. 1999; 878:228-35. DOI: 10.1111/j.1749-6632.1999.tb07688.x. View

Laxton R, Hu Y, Duchene J, Zhang F, Zhang Z, Leung K . A role of matrix metalloproteinase-8 in atherosclerosis. Circ Res. 2009; 105(9):921-9. PMC: 2853782. DOI: 10.1161/CIRCRESAHA.109.200279. View

Tuomainen A, Nyyssonen K, Laukkanen J, Tervahartiala T, Tuomainen T, Salonen J . Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Thromb Vasc Biol. 2007; 27(12):2722-8. DOI: 10.1161/ATVBAHA.107.154831. View

Johnson J, Carson K, Williams H, Karanam S, Newby A, Angelini G . Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation. 2005; 111(11):1422-30. DOI: 10.1161/01.CIR.0000158435.98035.8D. View

10.

Lehrke M, Greif M, Broedl U, Lebherz C, Laubender R, Becker A . MMP-1 serum levels predict coronary atherosclerosis in humans. Cardiovasc Diabetol. 2009; 8:50. PMC: 2754422. DOI: 10.1186/1475-2840-8-50. View

11.

JUNQUEIRA L, Bignolas G, Brentani R . Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J. 1979; 11(4):447-55. DOI: 10.1007/BF01002772. View

12.

McQuibban G, Gong J, Wong J, Wallace J, Clark-Lewis I, Overall C . Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood. 2002; 100(4):1160-7. View

13.

Orbe J, Fernandez L, Rodriguez J, Rabago G, Belzunce M, Monasterio A . Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed. Atherosclerosis. 2003; 170(2):269-76. DOI: 10.1016/s0021-9150(03)00251-x. View

14.

Jguirim-Souissi I, Jelassi A, Slimani A, Addad F, Hassine M, Ben Hamda K . Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease. Coron Artery Dis. 2011; 22(6):388-93. DOI: 10.1097/MCA.0b013e3283478d40. View

15.

Van den Steen P, Husson S, Proost P, Van Damme J, Opdenakker G . Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase. Biochem Biophys Res Commun. 2003; 310(3):889-96. DOI: 10.1016/j.bbrc.2003.09.098. View

16.

Sukhova G, Schonbeck U, Rabkin E, Schoen F, Poole A, Billinghurst R . Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation. 1999; 99(19):2503-9. DOI: 10.1161/01.cir.99.19.2503. View

17.

Libby P . The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med. 2008; 263(5):517-27. PMC: 2562742. DOI: 10.1111/j.1365-2796.2008.01965.x. View

18.

Brown D, Desai K, Vakili B, Nouneh C, Lee H, Golub L . Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial. Arterioscler Thromb Vasc Biol. 2004; 24(4):733-8. DOI: 10.1161/01.ATV.0000121571.78696.dc. View

19.

Deguchi J, Aikawa E, Libby P, Vachon J, Inada M, Krane S . Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation. 2005; 112(17):2708-15. DOI: 10.1161/CIRCULATIONAHA.105.562041. View

20.

Lemaitre V, OByrne T, Borczuk A, Okada Y, Tall A, DArmiento J . ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest. 2001; 107(10):1227-34. PMC: 209293. DOI: 10.1172/JCI9626. View